JPH01261392A - アシル誘導体及びその製造方法 - Google Patents

アシル誘導体及びその製造方法

Info

Publication number
JPH01261392A
JPH01261392A JP63085490A JP8549088A JPH01261392A JP H01261392 A JPH01261392 A JP H01261392A JP 63085490 A JP63085490 A JP 63085490A JP 8549088 A JP8549088 A JP 8549088A JP H01261392 A JPH01261392 A JP H01261392A
Authority
JP
Japan
Prior art keywords
formula
tables
formulas
methyl
chemical formulas
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP63085490A
Other languages
English (en)
Japanese (ja)
Inventor
Andre Furlenmeier
アンドレ・ファーレンマイアー
Erwin Gotschi
エルヴィン・ゴッチ
Paul Hebeisen
パウル・ヘバイゼン
Werner Hofheinz
ヴェルナー・ホフハインツ
Helmut Link
ヘルムト・リンク
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of JPH01261392A publication Critical patent/JPH01261392A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/36—Methylene radicals, substituted by sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Cephalosporin Compounds (AREA)
  • Saccharide Compounds (AREA)
JP63085490A 1987-04-10 1988-04-08 アシル誘導体及びその製造方法 Pending JPH01261392A (ja)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
CH1407/87-1 1987-04-10
CH140787 1987-04-10
CH1657/87-2 1987-04-30
CH165787 1987-04-30
CH2414/87-3 1987-06-26
CH241487 1987-06-26

Publications (1)

Publication Number Publication Date
JPH01261392A true JPH01261392A (ja) 1989-10-18

Family

ID=27172952

Family Applications (1)

Application Number Title Priority Date Filing Date
JP63085490A Pending JPH01261392A (ja) 1987-04-10 1988-04-08 アシル誘導体及びその製造方法

Country Status (15)

Country Link
US (1) US5055572A (fr)
EP (1) EP0286144A3 (fr)
JP (1) JPH01261392A (fr)
KR (1) KR880012611A (fr)
AU (1) AU611428B2 (fr)
DK (1) DK170088A (fr)
FI (1) FI881641A7 (fr)
HU (1) HU201948B (fr)
IL (1) IL85970A0 (fr)
MC (1) MC1920A1 (fr)
NO (1) NO881530L (fr)
NZ (1) NZ224130A (fr)
PH (1) PH24960A (fr)
PT (1) PT87202B (fr)
YU (1) YU70888A (fr)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2014522830A (ja) * 2011-07-07 2014-09-08 武田薬品工業株式会社 ピリミジノン化合物およびそれらの使用
US9750748B2 (en) 2012-12-17 2017-09-05 Takeda Pharmaceutical Company Limited Pyridazinones as DAAO enzyme inhibitors
US9931340B2 (en) 2011-08-22 2018-04-03 Takeda Pharmaceutical Company Limited Pyridazinone compounds and their use as DAAO inhibitors
US10202399B2 (en) 2011-11-15 2019-02-12 Takeda Pharmaceutical Company Limited Dihydroxy aromatic heterocyclic compound

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI872879A7 (fi) * 1986-07-21 1988-01-22 Sankei Yakuhin Kk --laktamfoerening, foerfarande foer dess framstaellning, denna innehaollande laekemedelskomposition foer behandling av sjukdom med bakterieinfektion samt mellanprodukter foer dess syntes.
NZ225383A (en) * 1987-08-07 1990-03-27 Sankei Yakuhin Kk Cephalosporin derivatives and pharmaceutical compositions
EP0366189A3 (fr) * 1988-10-24 1992-01-02 Norwich Eaton Pharmaceuticals, Inc. Lactames-quinolones antimicrobiennes
DE3939533A1 (de) * 1989-11-30 1991-06-06 Bayer Ag Neue cephalosporine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
EP0544166A3 (en) * 1991-11-26 1993-11-03 Hoffmann La Roche Cephalosporinderivatives
CN110655526A (zh) * 2018-06-28 2020-01-07 中国科学院上海药物研究所 头孢菌素-铁载体轭合物及其制备方法和用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60142987A (ja) * 1983-12-29 1985-07-29 Mochida Pharmaceut Co Ltd セフアロスポリン誘導体
EP0150507B1 (fr) * 1983-12-29 1992-08-05 Mochida Pharmaceutical Co., Ltd. Dérivés de céphalosporine, procédés pour leur péparation et compositions pharmaceutiques
EP0189287B1 (fr) * 1985-01-21 1992-12-16 Nippon Pharmaceutical Development Institute Company Limited Bêta-lactames antibiotiques
AU586229B2 (en) * 1985-04-01 1989-07-06 Mochida Pharmaceutical Co., Ltd. Cephalosporin derivatives
FI872879A7 (fi) * 1986-07-21 1988-01-22 Sankei Yakuhin Kk --laktamfoerening, foerfarande foer dess framstaellning, denna innehaollande laekemedelskomposition foer behandling av sjukdom med bakterieinfektion samt mellanprodukter foer dess syntes.
US4880798A (en) * 1986-11-25 1989-11-14 Mochida Pharmaceutical Co., Ltd. Cephalosporin derivatives

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2014522830A (ja) * 2011-07-07 2014-09-08 武田薬品工業株式会社 ピリミジノン化合物およびそれらの使用
US10085986B2 (en) 2011-07-07 2018-10-02 Takeda Pharmaceutical Company Limited Pyrimidinone compounds and their use
US9931340B2 (en) 2011-08-22 2018-04-03 Takeda Pharmaceutical Company Limited Pyridazinone compounds and their use as DAAO inhibitors
US10463663B2 (en) 2011-08-22 2019-11-05 Takeda Pharmaceutical Company Limited Pyridazinone compounds and their use as DAAO inhibitors
US11129828B2 (en) 2011-08-22 2021-09-28 Takeda Pharmaceutical Company Limited Pyridazinone compounds and their use as DAAO inhibitors
US12186313B2 (en) 2011-08-22 2025-01-07 Takeda Pharmaceutical Company Limited Pyridazinone compounds and their use as DAAO inhibitors
US10202399B2 (en) 2011-11-15 2019-02-12 Takeda Pharmaceutical Company Limited Dihydroxy aromatic heterocyclic compound
US9750748B2 (en) 2012-12-17 2017-09-05 Takeda Pharmaceutical Company Limited Pyridazinones as DAAO enzyme inhibitors

Also Published As

Publication number Publication date
DK170088A (da) 1988-10-11
AU1431088A (en) 1988-10-13
PT87202B (pt) 1992-07-31
PT87202A (pt) 1988-05-01
MC1920A1 (fr) 1989-04-06
NO881530D0 (no) 1988-04-08
DK170088D0 (da) 1988-03-28
KR880012611A (ko) 1988-11-28
IL85970A0 (en) 1988-09-30
YU70888A (en) 1989-12-31
HU201948B (en) 1991-01-28
PH24960A (en) 1990-12-26
EP0286144A3 (fr) 1990-10-03
FI881641A0 (fi) 1988-04-08
EP0286144A2 (fr) 1988-10-12
FI881641A7 (fi) 1988-10-11
NO881530L (no) 1988-10-11
HUT46920A (en) 1988-12-28
US5055572A (en) 1991-10-08
NZ224130A (en) 1991-02-26
AU611428B2 (en) 1991-06-13

Similar Documents

Publication Publication Date Title
AU604868B2 (en) 3-(substituted-(pyrazolo/s-triazolo)(1,5-a) pyrimidinylthiomethyl)-7-acyl-cephalosporin derivatives
DE3485860T2 (de) Cephalosporinverbindungen, verfahren zu ihrer herstellung und pharmazeutishe praeparate.
JPS59172493A (ja) 化合物
EP0034760A1 (fr) Dérivés de céphalosporine, des compositions pharmaceutiques les contenant et procédé pour leur préparation
CS264257B2 (en) Process for preparing new derivatives of cephalosporine
JPS63146863A (ja) カルボン酸類
EP0197409A1 (fr) Dérivés de céphalosporine
JP2007023046A (ja) 抗細菌セファロスポリン類
DK149282B (da) Analogifremgangsmaade til fremstilling af et cephemderivat
CS232735B2 (en) Method of making cephalosporine derivatives
BE897864A (fr) Procede de production de composes de 3-vinyl-3-cephem 7-substitues et nouveaux produits ainsi obtenus
JPH01261392A (ja) アシル誘導体及びその製造方法
EP0303172A2 (fr) Oxyimino-céphalosporines
JPH0369354B2 (fr)
EP0267733A2 (fr) Dérivés de céphalosporine, leur procédé de préparation et compositions pharmaceutiques les contenant
EP0049855B1 (fr) Dérivés de céphalosporine, leur préparation, compositions pharmaceutiques les contenant et intermédiaires pour leur préparation
JPS62294687A (ja) ７−アシルアミノ−３−ビニル−３−セフエム化合物
JPH0516437B2 (fr)
JPH08502734A (ja) 新規セファロスポリン誘導体およびその製造方法
DE69123550T2 (de) Cephemverbindungen, Verfahren zu ihrer Herstellung und antibakterielle Präparate
JPS61251685A (ja) 新規な１−オキサ−１−デチアセフアロスポリン化合物及びそれを含む抗菌剤
KR0154901B1 (ko) 신규 세팔로스포린계 항생제(v)
JPH04266889A (ja) 抗生物質ｃ−３カテコ−ル−置換セファロスボリン化合物、組成物およびその使用法
DE2805608A1 (de) Neue cephalosporin-derivate, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
JPH07501311A (ja) 新規な３−縮合ピリジニウムメチルセファロスポリン化合物